Rate My Professor Pierre Chapuis

Professor Pierre Chapuis AM, DS (Qld), FRACS, is a Clinical Professor and Professor Emeritus in the Discipline of Surgery at the University of Sydney's Concord Clinical School, Faculty of Medicine and Health. He graduated from the University of Queensland in 1969, obtained his Fellowship of the Royal Australasian College of Surgeons (FRACS) in 1975, and was awarded the Doctor of Surgery (DS) by the University of Queensland in 1984 for his thesis "A clinicopathological study of large bowel cancer." His international training included registrar posts in the United Kingdom in 1976, followed by fellowships at St Mark's Hospital in London and the Centre Léon Bérard in Lyon, France. Upon returning to Sydney in 1978, he held positions as Fellow in Coloproctology at Sydney Hospital and First Assistant at Sydney Adventist Hospital. In 1979, he became Senior Research Fellow in the Department of Surgery at the University of Sydney, Concord Hospital, and in 1982 received the John Loewenthal Research Fellowship from the Royal Australasian College of Surgeons. He entered full-time practice in 1984 as a staff specialist in the Colorectal Unit at Concord Hospital and Senior Lecturer, was promoted to Professor of Surgery and Director of Postgraduate Surgical Education in 2014, and attained Professor Emeritus status in 2021.

A pioneering colorectal surgeon with over 40 years of service at Concord Hospital, Professor Chapuis manages the Colorectal Cancer Health Outcomes & Values Research Project, the world's largest single-unit colorectal cancer database, profoundly impacting international staging and understanding of colorectal surgery. His academic interests center on prognostic factors, multidisciplinary care, and endoscopic palliation in colorectal cancer. He has supervised numerous PhD students, led the Master of Surgery program, mentored surgeons including Associate Professor Sarah Aitken, and directed postgraduate surgical education in the Discipline of Surgery. Key publications include "Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management" (2024), "Splenic Flexure Cancer Survival: A 25-year Experience and Implications for Complete Mesocolic Excision (CME) and Central Vascular Ligation (CVL)" (2023), "Right vs. Left Colorectal Cancer – Where Do We Draw the Line?" (2024), and "The Association Between Tumour Sub-site and Local Nodal and/or Distant Metastasis at the Time of Resection of Colorectal Cancer" (2022). A foundation member of the Colorectal Surgical Society of Australia and New Zealand, he edited the Australian and New Zealand Journal of Surgery for decades and served on the Royal Australasian College of Surgeons’ Anatomy and Pathology examination committee. Honors include the Member of the Order of Australia (AM) in 2020 for services to medical education and colorectal surgery, and Honorary Consultant Emeritus at Concord Hospital in 2024.